Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system

被引:57
作者
Nakayama, Y [1 ]
Sakamoto, H [1 ]
Satoh, K [1 ]
Yamamoto, T [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1780861, Japan
关键词
estrogen receptor beta; thymidylate synthase; survivin; telomerase; colon cancer;
D O I
10.1016/S0304-3835(00)00600-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Estrogen receptor beta (ER beta) mediated system was tested in three colon cancer cell lines with different sensitivities. These cell lines express ER beta and androgen receptor (AR) but not the classic estrogen receptor ER alpha. Combinations of ER beta ligands such as estradiol (E-2), 17 epiestriol (17E(3)), quercetin (Q with tamoxifen (TMX) showed marked growth inhibition. The IC50 were: 2.0 +/- 0.3 x 10(-15), 3.0 +/- 1.3 x 10(-10) and 1.2 +/- 0.5 x 10(-14) M for DLD-1, DLD-1/5FU and DLD-1/FdUrd. respectively (TMX + E-2 treatment, mean +/- SD, n = 3). The IC50 of TMX + 17E(3) were 3.5 +/- 1.8 x 10(-8), 2.6 +/- 0.9 x 10(-8) and 1.4 +/- 1.1 x 10(-14) M and that of TMX + Q treatment were 3.4 +/- 2.1 x 10(-9), 3.6 +/- 0.2 x 10(-9) and 2.6 +/- 1.1 x 10(-9) M, respectively. This inhibition was significantly different from single agent treatment at the probability level of P < 0.002. Thymidylate synthase expression and survivin expression were also markedly inhibited. The inhibition was highest with TMX + Q and lowest with TMX + dehydroepiandrosterone (DHEA). The expression of telomerase was also inhibited by TMX but combination with ER<beta> agonists reversed the inhibition. The cellular sensitivity to 5FU was increased: TMX + E-2, TMX + 17E(3) and TMX + Q were 1.7 +/- 0.5 x 10(-5), 8.4 +/- 3.2 x 10(-8), 8.2 +/- 2.9 x 10(-8) and 6.3 +/- 3.3 x 10(-8) M for DLD-1 cells and 7.7 +/- 4.8 x 10(-5), 9.1 +/- 4.9 x 10(-7), 1.5 +/- 0.3 x 10(-9) and 5.7 +/- 2.2 x 10(-8) M for DLD-1/5FU. DLD-1/FdUrd cells had IC50 of 8.5 +/- 6.1 x 10(-5), 1.8 +/- 0.8 x 10(-8), 37 +/- 1.1 x 10(-9) and 1.6 +/- 1.1 x 10(-9) M (mean +/- SD) for the control, TMX + E-2, TMX + 17E3 and TMX + Q. The present data indicate that ERP ligands in combination with TMX may have tumor static effects on colon cancer cells. (C) 2000 Elsevier Science Ireland Ltd. Ail rights reserved.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 17 条
[1]   Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists [J].
Barkhem, T ;
Carlsson, B ;
Nilsson, Y ;
Enmark, E ;
Gustafsson, JÅ ;
Nilsson, S .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :105-112
[2]   Oestrogen receptors -: an overview [J].
Enmark, E ;
Gustafsson, JÅ .
JOURNAL OF INTERNAL MEDICINE, 1999, 246 (02) :133-138
[3]   Functional estrogen receptor β in colon cancer cells [J].
Fiorelli, G ;
Picariello, L ;
Martineti, V ;
Tonelli, F ;
Brandi, ML .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) :521-527
[4]  
Hilgenfeld R U, 1996, Recent Results Cancer Res, V142, P353
[5]  
KINOSHITA K, 1999, NIHON U J MED, V41, P1
[6]  
Korenaga D, 1997, HEPATO-GASTROENTEROL, V44, P78
[7]   Sex hormone-receptor-negative tumors have a higher proliferative activity than sex hormone-receptor-positive tumors in human adenocarcinomas of the gastrointestinal tract [J].
Korenaga, D ;
Orita, H ;
Okuyama, T ;
Kinoshita, J ;
Maekawa, S ;
Ikeda, T ;
Sugimachi, K .
SURGERY TODAY, 1998, 28 (10) :1007-1014
[8]   Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β [J].
Kuiper, GGJM ;
Lemmen, JG ;
Carlsson, B ;
Corton, JC ;
Safe, SH ;
van der Saag, PT ;
van der Burg, P ;
Gustafsson, JÄ .
ENDOCRINOLOGY, 1998, 139 (10) :4252-4263
[9]   The novel estrogen receptor-beta subtype: Potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens [J].
Kuiper, GGJM ;
Gustafsson, JA .
FEBS LETTERS, 1997, 410 (01) :87-90
[10]   Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro [J].
Lindner, DJ ;
Borden, EC .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (11) :681-693